Article info
PDFEditorial commentary
Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease
- Correspondence to Professor Maurizio Pocchiari, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome 161, Italy; maurizio.pocchiari{at}iss.it
Citation
Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease
Publication history
- Received January 8, 2015
- Accepted January 12, 2015
- First published January 28, 2015.
Online issue publication
April 16, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions